KIT and cancer: The toxic effect of this RNase toward cancer cells is due to expression of specific oncogenes, e.g., KIT, RAS, AML1/ETO, and FLT3.1, whose mutations lead to activation of signaling pathways in various cancer cells and their uncontrolled proliferation [56,57].